Rankings
▼
Calendar
PRAX Q2 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$781,000
Gross Profit
-$25M
-3179.6% margin
Operating Income
-$35M
-4476.3% margin
Net Income
-$34M
-4393.3% margin
EPS (Diluted)
$-7.38
QoQ Revenue Growth
+14.3%
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$31M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$133M
Total Liabilities
$28M
Stockholders' Equity
$106M
Cash & Equivalents
$124M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$781,000
$0
—
Gross Profit
-$25M
-$3M
-731.4%
Operating Income
-$35M
-$60M
+42.1%
Net Income
-$34M
-$60M
+43.0%
Revenue Segments
License
$800,000
100%
← FY 2023
All Quarters
Q3 2023 →